A phase II and biomarker study of an irreversible pan-human EGF receptor (HER) tyrosine kinase inhibitor dacomitinib in patients with recurrent and/or metastatic squamous cell carcinoma of esophagus.

Hyo Song Kim; Han Sang Kim; Jong-Mu Sun; Myung-Ju Ahn; Keunchil Park; Hoon-Gu Kim; Ik-Joo Chung; Jong-Seok Lee; Se-Hoon Lee; Kyung Hee Lee; Dae Joon Kim; Hye Ryun Kim; Joo-Hang Kim; Byoung Chul Cho

doi:10.1200/jco.2014.32.15_suppl.4083

A phase II and biomarker study of an irreversible pan-human EGF receptor (HER) tyrosine kinase inhibitor dacomitinib in patients with recurrent and/or metastatic squamous cell carcinoma of esophagus.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.4083 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 4083-4083

Author(s):

Hyo Song Kim ◽

Han Sang Kim ◽

Jong-Mu Sun ◽

Myung-Ju Ahn ◽

Keunchil Park ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Egf Receptor ◽

Kinase Inhibitor ◽

Metastatic Squamous Cell Carcinoma ◽

Carcinoma Of Esophagus

Download Full-text

Abstract CT229: A phase II and biomarker study of an irreversible pan-human EGF receptor (HER) tyrosine kinase inhibitor, dacomitinib, in patients with recurrent and/or metastatic squamous cell carcinoma of head and neck (R/M-SCCHN)

10.1158/1538-7445.am2014-ct229 ◽

2014 ◽

Author(s):

Han Sang Kim ◽

Hyung Joo Kwon ◽

Myung-Ju Ahn ◽

Byung Woog Kang ◽

Jong-Mu Sun ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Egf Receptor ◽

Kinase Inhibitor ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

Phase II study of oral lapatinib, a dual-tyrosine kinase inhibitor, combined with chemoradiotherapy (CRT) in patients (pts) with locally advanced, unresected squamous cell carcinoma of the head and neck (SCCHN).

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.5505 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 5505-5505 ◽

Cited By ~ 13

Author(s):

K. J. Harrington ◽

A. Berrier ◽

M. Robinson ◽

E. Remenar ◽

M. Housset ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Kinase Inhibitor ◽

Phase Ii Study ◽

Locally Advanced

Download Full-text

EGFR blockade by tyrosine kinase inhibitor or monoclonal antibody inhibits growth, directs terminal differentiation and induces apoptosis in the human squamous cell carcinoma HN5.

International Journal of Oncology ◽

10.3892/ijo.13.2.335 ◽

1998 ◽

Author(s):

H Modjtahedi ◽

K Affleck ◽

C Stubberfield ◽

C Dean

Keyword(s):

Monoclonal Antibody ◽

Squamous Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Squamous Cell ◽

Kinase Inhibitor ◽

Terminal Differentiation ◽

Human Squamous Cell Carcinoma

Download Full-text

A phase II study of oxaliplatin in combination with leucovorin and fluorouracil as first-line chemotherapy in patients with metastatic squamous cell carcinoma of esophagus

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-013-2081-5 ◽

2013 ◽

Vol 71 (4) ◽

pp. 905-911 ◽

Cited By ~ 17

Author(s):

Jialei Wang ◽

Jianhua Chang ◽

Hui Yu ◽

Xianghua Wu ◽

Huijie Wang ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

First Line ◽

Metastatic Squamous Cell Carcinoma ◽

Carcinoma Of Esophagus ◽

Line Chemotherapy

Download Full-text

Acquired resistance to EGFR tyrosine kinase inhibitor in A431 squamous cell carcinoma xenografts is mediated by c-Kit pathway transduction

Tumor Biology ◽

10.1007/s13277-014-2932-7 ◽

2014 ◽

Vol 36 (4) ◽

pp. 2993-2999 ◽

Cited By ~ 3

Author(s):

Lixia Zhang ◽

Xiaokun Yang ◽

Bei Zhao ◽

Zhen Cai

Keyword(s):

Squamous Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Squamous Cell ◽

Kinase Inhibitor ◽

Acquired Resistance ◽

Egfr Tyrosine Kinase Inhibitor ◽

Egfr Tyrosine Kinase

Download Full-text

Squamous cell carcinoma transformation of lung adenocarcinoma after tyrosine kinase inhibitor therapy: Cytological approach

Cytopathology ◽

10.1111/cyt.12813 ◽

2020 ◽

Vol 31 (3) ◽

pp. 232-235 ◽

Cited By ~ 1

Author(s):

Alexandra Grosse ◽

Claudia Grosse

Keyword(s):

Squamous Cell Carcinoma ◽

Tyrosine Kinase ◽

Lung Adenocarcinoma ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Squamous Cell ◽

Kinase Inhibitor ◽

Inhibitor Therapy ◽

Tyrosine Kinase Inhibitor Therapy

Download Full-text

Phase II trial of paclitaxel and cisplatin combination given biweekly as first-line chemotherapy in patients with advanced or metastatic squamous cell carcinoma of esophagus from a single center in China.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.e14646 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. e14646-e14646

Author(s):

Y. Zhou ◽

J. Huang ◽

L. Yang ◽

G. R. Cai ◽

H. B. Xu ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Trial ◽

Single Center ◽

First Line ◽

Metastatic Squamous Cell Carcinoma ◽

Carcinoma Of Esophagus ◽

Line Chemotherapy

Download Full-text

Deguelin Potentiates Apoptotic Activity of an EGFR Tyrosine Kinase Inhibitor (AG1478) in PIK3CA-Mutated Head and Neck Squamous Cell Carcinoma

International Journal of Molecular Sciences ◽

10.3390/ijms18020262 ◽

2017 ◽

Vol 18 (2) ◽

pp. 262 ◽

Cited By ~ 4

Author(s):

Yuh Baba ◽

Toyonobu Maeda ◽

Atsuko Suzuki ◽

Satoshi Takada ◽

Masato Fujii ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Kinase Inhibitor ◽

Neck Squamous Cell Carcinoma ◽

Egfr Tyrosine Kinase Inhibitor ◽

Apoptotic Activity

Download Full-text

Transformation to a squamous cell carcinoma phenotype of an EGFR-mutated NSCLC patient after treatment with an EGFR-tyrosine kinase inhibitor

Journal of Clinical Pathology ◽

10.1136/jclinpath-2015-202866 ◽

2015 ◽

Vol 68 (4) ◽

pp. 320-321 ◽

Cited By ~ 26

Author(s):

Justine L Kuiper ◽

Merle I Ronden ◽

Annemarie Becker ◽

Daniëlle A M Heideman ◽

Peter van Hengel ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Squamous Cell ◽

Kinase Inhibitor ◽

Nsclc Patient ◽

Egfr Tyrosine Kinase Inhibitor ◽

Egfr Tyrosine Kinase ◽

Egfr Mutated

Download Full-text

Targeted molecular therapy of head and neck squamous cell carcinoma with the tyrosine kinase inhibitor vandetanib in a mouse model

Head & Neck ◽

10.1002/hed.21455 ◽

2010 ◽

pp. n/a-n/a ◽

Cited By ~ 5

Author(s):

Daisuke Sano ◽

David R. Fooshee ◽

Mei Zhao ◽

Genevieve A. Andrews ◽

Mitchell J. Frederick ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Mouse Model ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Kinase Inhibitor ◽

Molecular Therapy ◽

Targeted Molecular Therapy

Download Full-text